Home > Ad Gallery > Pharmaceutical Product ads > Canada > HCP - Canada > Depression-Bipolarity
The full-size photo is available to registered users. Registration is free.
Venlafaxine. plein la vue.
Venlafaxine (Effexor, Efexor) is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class first introduced by Wyeth in 1993. It is prescribed for the treatment of major depression and anxiety disorders, among other uses. Due to the pronounced side effects and suspicions that venlafaxine may significantly increase the risk of suicide, it is not recommended as a first line treatment of depression. However, it is often effective for depression not responding to SSRIs. Venlafaxine was the sixth most widely-used antidepressant based on the number of retail prescriptions in the US (17.1 million) in 2006.
Cymbalta-MedPost080909.jpg RivaVenlafaxine-ActPharm0808.jpg Risperdal-JPsychNeuroscience0805.jpg
Rate this file (No vote yet)
Rubbish
Poor
Fair
Good
Excellent
Great
File information
Album name:admin / Depression-Bipolarity
Keywords:Laboratoire Riva Venlafaxine Effexor generic anti-depressant SSRI HCP Single-page print ad L'Actualité Pharmaceutique August 2008 Billboard outdoor
Country:Canada
Source:L'Actualité Pharmaceutique
File Size:1473 KB
Date added:Aug 15, 2008
Dimensions:1595 x 2199 pixels
Displayed:42 times
URL:http://adpharm.net/displayimage-10567.html
Favorites:Add to Favorites
RSS feed Add to Google Add to My Yahoo!



Green Web Hosting! This site hosted by DreamHost.